Concepedia

Thomas R. Belliotti

TR

Statistics

Publications

9

Citations

659

H-Index

9

Active since

1991

Affiliations

Pfizer (United States)(Current)

Thomas R. Belliotti is an author at Pfizer (United States) specializing in medicinal chemistry, pharmacology, and pharmacy.

Publications per year

1991–2017

9

Publications

9

Isoindolinone enantiomers having affinity for the dopamine D4 receptor

Thomas R. Belliotti, Wouter A. Brink, Suzanne R. Kesten et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 213 citations · Full text

, , +11

Structure−Activity Relationships of Pregabalin and Analogues That Target the α<sub>2</sub>-δ Protein

Thomas R. Belliotti, Thomas Capiris, I. Victor Ekhato et al. · Journal of Medicinal Chemistry · 2005 · 210 citations

, , +17

Styrylpyrazoles, styrylisoxazoles, and styrylisothiazoles. Novel 5-lipoxygenase and cyclooxygenase inhibitors

Thomas R. Belliotti, Amal M. Boctor, D. T. CONNOR et al. · Journal of Medicinal Chemistry · 1991 · 91 citations · Full text

, , +11

Aminopyrimidines with High Affinity for Both Serotonin and Dopamine Receptors

David J. Wustrow, Thomas R. Belliotti, Shelly A. Glase et al. · Journal of Medicinal Chemistry · 1998 · 30 citations · Full text

, , +17

Discovery of 6-ethyl-2,4-diaminopyrimidine-based small molecule renin inhibitors

Daniel D. Holsworth, Mehran Jalaie, Thomas R. Belliotti et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 29 citations · Full text

, , +10

1–5 of 9